End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.7 TWD | +0.59% | -0.47% | -11.78% |
May. 06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 604M 18.65M | Sales 2023 | 622M 19.19M | Capitalization | 4.3B 133M |
---|---|---|---|---|---|
Net income 2022 | 139M 4.29M | Net income 2023 | 166M 5.12M | EV / Sales 2022 | 5.35 x |
Net cash position 2022 | 800M 24.67M | Net cash position 2023 | 431M 13.3M | EV / Sales 2023 | 6.23 x |
P/E ratio 2022 |
29.1
x | P/E ratio 2023 |
26.2
x | Employees | - |
Yield 2022 |
1.05% | Yield 2023 |
-
| Free-Float | 55.26% |
1 day | +0.59% | ||
1 week | -0.47% | ||
Current month | -0.47% | ||
1 month | -5.74% | ||
3 months | -8.37% | ||
6 months | -12.68% | ||
Current year | -11.78% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Ting Chen
CEO | Chief Executive Officer | - | 21-11-02 |
Ruei Yi Wu
DFI | Director of Finance/CFO | - | 23-03-21 |
Yi Hua Yu
DFI | Director of Finance/CFO | - | 18-06-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yong Xiang Lin
CHM | Chairman | - | 21-07-11 |
Xiu Yuan Li
BRD | Director/Board Member | - | 15-06-21 |
Zhen Zhen Fu
BRD | Director/Board Member | - | 21-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 42.7 | +0.59% | 73,014 |
24-05-07 | 42.45 | -0.82% | 95,522 |
24-05-06 | 42.8 | -0.23% | 105,104 |
24-05-03 | 42.9 | -0.23% | 115,340 |
24-05-02 | 43 | +0.23% | 112,767 |
End-of-day quote Taiwan S.E., May 07, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-11.78% | 117M | |
+0.28% | 257B | |
+15.05% | 19.66B | |
0.00% | 18.62B | |
+5.60% | 11.04B | |
-12.32% | 9.45B | |
+13.59% | 7.4B | |
+14.29% | 6.2B | |
+4.14% | 4.78B | |
-17.73% | 3.79B |
- Stock Market
- Equities
- 1783 Stock